New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Basel [u.a.]
Karger
1996
|
Schriftenreihe: | Developments in biological standardization
87 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV010937795 | ||
003 | DE-604 | ||
005 | 20210702 | ||
007 | t| | ||
008 | 960902s1996 gw d||| |||| 10||| eng d | ||
016 | 7 | |a 948321539 |2 DE-101 | |
020 | |a 3805563094 |c kart. : DM 383.00 |9 3-8055-6309-4 | ||
035 | |a (OCoLC)312417634 | ||
035 | |a (DE-599)BVBBV010937795 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
044 | |a gw |c DE | ||
049 | |a DE-12 |a DE-355 |a DE-11 | ||
084 | |a XD 3300 |0 (DE-625)152554:12905 |2 rvk | ||
084 | |a XD 3305 |0 (DE-625)152554:12911 |2 rvk | ||
245 | 1 | 0 | |a New approaches to stabilisation of vaccines potency |b proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables |c vol. ed. Fred Brown ... |
264 | 1 | |a Basel [u.a.] |b Karger |c 1996 | |
300 | |a XI, 356 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Developments in biological standardization |v 87 | |
500 | |a Literaturangaben | ||
650 | 0 | 7 | |a Biologische Standardisierung |0 (DE-588)4336303-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Stabilisierung |0 (DE-588)4357300-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Haltbarkeit |0 (DE-588)4220913-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelstabilität |0 (DE-588)4122835-2 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1993 |z Genf |2 gnd-content | |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1995 |z Genf |2 gnd-content | |
689 | 0 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
689 | 0 | 1 | |a Stabilisierung |0 (DE-588)4357300-9 |D s |
689 | 0 | 2 | |a Biologische Standardisierung |0 (DE-588)4336303-9 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
689 | 1 | 1 | |a Haltbarkeit |0 (DE-588)4220913-4 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
689 | 2 | 1 | |a Arzneimittelstabilität |0 (DE-588)4122835-2 |D s |
689 | 2 | |5 DE-604 | |
700 | 1 | |a Brown, Fred |d 1925-2004 |e Sonstige |0 (DE-588)171991923 |4 oth | |
830 | 0 | |a Developments in biological standardization |v 87 |w (DE-604)BV000000884 |9 87 | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007316551&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-007316551 |
Datensatz im Suchindex
DE-BY-UBR_call_number | 00/XD 3305 D489 |
---|---|
DE-BY-UBR_katkey | 2250438 |
DE-BY-UBR_location | 00 |
DE-BY-UBR_media_number | 069009484569 |
_version_ | 1822712273648484352 |
adam_text | JL1S5- NEW APPROACHES TO STABILISATION OF VACCINES POTENCY WHO
HEADQUARTERS, GENEVA MAY 29-31, 1995 VOLUME EDITOR FRED BROWN PLUM
ISLAND ANIMAL DISEASE CENTER GREENPORT NY, USA PROCEEDINGS OF A
SYMPOSIUM ORGANIZED BY THE WORLD HEALTH ORGANIZATION AND THE
INTERNATIONAL ASSOCIATION OF BIOLOGICAL STANDARDIZATION (IABS TASK FORCE
ON VACCINES) 57 FIGURES AND 80 TABLES, 1996 T A I) F C I) BASEL
FREIL3UR 8 PARIS LONDON * NEW YORK * L / LVVJ C IV NEW DELHI *
BANGKOK * SINGAPORE * TOKYO * SYDNEY CONTENTS KEYNOTE ADDRESS.. J.W. LEE
SESSION I CURRENT REQUIREMENTS AND STRATEGIES FOR VACCINE STABILISATION
7 CHAIRMEN: F. HORAUD, J.W. LEE AND F. ANDRE VACCINE TRANSPORT AND
STORAGE: ENVIRONMENTAL CHALLENGES 9 M. ZAFFRAN VACCINE STABILITY IN THE
CONTEXT OF VACCINE DELIVERY IN A DEVELOPING COUNTRY: INDIA 19 T.J. JOHN
PROBLEMS ENCOUNTERED IN THE DELIVERY AND STORAGE OF OPV IN AN AFRICAN
COUNTRY 27 B.D. SCHOUB, N.A. CAMERON EXPERIENCE WITH VETERINARY VACCINES
IN WARM CLIMATES 33 /./. TULASNE, P. C. LEFEVRE, J. BLANCOU SESSION II
FUTURE NEEDS: WILL STABILITY REMAIN AN ISSUE FOR 21ST CENTURY VACCINES?
43 CHAIRMEN: J. JOHN AND P.D. MINOR RESEARCH PRIORITIES FOR THE WHO
GLOBAL PROGRAMME FOR VACCINES AND IMMUNIZATION 45 P.-H. LAMBERT RECENT
DEVELOPMENTS IN THE DESIGN OF VIRAL VACCINES 51 P.D. MINOR RECENT TRENDS
IN THE DEVELOPMENTS OF BACTERIAL VACCINES 59 A.A. LINDBERG, S. PILLAI
PROGRESS ON VACCINES AGAINST PARASITES 73 H.D. ENGERS, R. BERGQUIST, F.
MODABBER DEVELOPMENTS IN IMMUNIZATION PRACTICES AND STRATEGIES:
IMPLICATIONS FOR VACCINE STABILITY 85 S.A. PLOTKIN, M.A. FLETCHER
SESSION III REASONS FOR INSTABILITY OF EXISTING VACCINES 95 CHAIRMEN: F.
BROWN AND M.H. V. V. REGENMORTEL FACTORS AFFECTING THE STABILITY OF
VIRAL VACCINES 97 /. PEETERMANS STABILISING ORAL POLIOVACCINE AT HIGH
AMBIENT TEMPERATURES 103 J.F.E. NEWMAN, S. TIRRELL, C. ULLMAN, P.G.
PIATTI, F. BROWN REASONS FOR INSTABILITY OF BACTERIAL VACCINES 113 M.J.
CORBEL THE REACTION OF BACTERIAL TOXINS WITH FORMALDEHYDE AND ITS USE
FOR ANTIGEN STABILIZATION 125 J. PETRE, M. PIZZA, L. NENCIONI, A. PODDA,
M. T. DE MAGISTRIS, R. RAPPUOLI IX ANALYSIS OF VACCINE STABILITY 135
D.B. VOLKIN, C.J. BURKE, G. SANYAL, C.R. MIDDAUGH PHYSICOCHEMICAL
STUDIES OF THE STRUCTURE AND STABILITY OF POLYSACCHARIDE-PROTEIN
CONJUGATE VACCINES 143 C. JONES, D.T. CRANE, X. LEMERCINIER, B.
BOLGIANO, S.E. YOST SESSION IV NEW APPROACHES TO VACCINE STABILISATION
(1) 153 CHAIRMAN: J.L. MELNICK THERMOSTABILITY OF POLIOVIRUS AND MEASLES
VACCINES 155 J.L. MELNICK THE REPLACEMENT OF WATER WITH DEUTERIUM OXIDE
SIGNIFICANTLY IMPROVES THE THERMAL STABILITY OF THE ORAL POLIOVIRUS
VACCINE 161 R. CRAINIC, R. WU, D. OTELEA, M. M. GEORGESCU, F.
DELPEYROUX, S. GUILLOT, J. BALANANT, M. TARDY-PANIT A VARICELLA VACCINE
STABLE AT 5C 167 B. FANGET, A. FRANCON STABILISATION OF POLIOVIRUS WITH
PIRODAVIR 173 B. ROMBAUT, K. ANDRIES, A. BOEYE REGULATORY CONSIDERATIONS
FOR NEW STABILISED POLIOVACCINES 181 J.B. MILSTIEN, S. LEMON SESSION V
NEW APPROACHES TO VACCINE STABILISATION (2) 191 CHAIRMEN: 5. PLOTKIN AND
P.-H. LAMBERT STABILISATION OF VACCINES USING TREHALOSE (Q-T4)
TECHNOLOGY 193 E.M. GRIBBON, S.D. SEN, B.J. ROSER, J. KAMPINGA POTENTIAL
OF CHIMAERIC PLANT VIRUS PARTICLES AS NOVEL, STABLE VACCINES 201 F. XU,
T.D. JONES, P.B. RODGERS PROTEIN STABILISATION USING ADDITIVES BASED ON
MULTIPLE ELECTROSTATIC INTERACTIONS 207 T.D. GIBSON STABILITY OF YELLOW
FEVER VACCINE 219 T.P. MONATH SESSION VI POSTER SESSION 227 CHAIRMAN:
D.I. MAGRATH VACCINE STABILITY NOT BY ELIMINATING THERMOLABILITY BUT
THROUGH THE ENVIRONMENTAL STABILITY (ABSTRACT) 229 S.C. ARYA
BIODEGRADABLE MICROPARTICLES AS PARENTERAL VACCINE DELIVERY SYSTEMS
(ABSTRACT) 231 A.G.A. COOMBES, E.C. LAVELLE, P.G. JENKINS, J. HOLLAND,
S.S. DAVIS SESSION VII NEW APPROACHES TO VACCINE STABILISATION (3) 233
CHAIRMEN: M.J. CORBEL AND R. CRAINIC STABILIZATION OF RINDERPEST VACCINE
BY MODIFICATION OF THE LYOPHILIZATION PROCESS 235 J.A. HOUSE, J.C.
MARINER CONTENTS STABILITY OF RECOMBINANT VACCINIA-RABIES VACCINE IN
VETERINARY USE 245 P.P. PASTORET, B. BROCHIER, B. LANGUET, C. DURET, G.
CHAPPUIS, P. DESMETTRE STABILISATION OF BCG VACCINES 251 M. GHEORGHIU,
M. LAGRANDERIE, A.M. BALAZUC STABILITY TESTING IN HAEMOPHILUS INFLUENZAE
TYPE B CONJUGATE VACCINES 263 B. KLUG GLYCOCONJUGATE VACCINES: FUTURE
COMBINATIONS 269 P.R. PARADISO, A.A. LINDBERG FACTORS INFLUENCING THE
STABILITY OF LIVE ORAL ATTENUATED BACTERIAL VACCINES 277 S.J. CRYZ JR.,
O. PASTERIS, SJ. VARALLYAY, E. FIIRER MIMICRY OF VIRAL EPITOPES WITH
RETRO-INVERSO PEPTIDES OF INCREASED STABILITY 283 N. BENKIRANE, G.
GUICHARD, J.P. BRIAND, S. MULLER, F. BROWN, M.H.V. VAN REGENMORTEL
STRATEGIES FOR STABILIZING TETANUS TOXOID TOWARDS THE DEVELOPMENT OF A
SINGLE-DOSE TETANUS VACCINE 293 S.P. SCHWENDEMAN, H.R.COSTANTINO, R.K.
GUPTA, M. TOBIO, A.-C. CHANG, M.J. ALONSO, G.R. SIBER, R. LANGER SESSION
VIII STANDARDIZATION OF VACCINE STABILITY: REGULATORY ISSUES 307
CHAIRMEN: E. GRIFFITHS AND M. HAASE STABILITY TESTING REQUIREMENTS FOR
VACCINES - DRAFT GUIDELINES OF THE INTERNATIONAL CONFE- RENCE ON
HARMONIZATION (ICH) 309 M. HAASE REGULATORY REQUIREMENTS FOR VETERINARY
VACCINE STABILITY IN THE EUROPEAN COMMUNITY 319 D. FAWTHROP REGULATORY
PRACTICES AND PROBLEMS WITH VACCINE STABILITY STUDIES AND THE
ESTABLISHMENT OF SHELF LIVES 329 A. FENYVES GENERAL DISCUSSION 335 D.I.
MAGRATH SESSION IX SUMMARY AND CONCLUSIONS 337 CHAIRMEN: G.C. SCHILD AND
F. HORAUD CONTENTS XI
|
any_adam_object | 1 |
author_GND | (DE-588)171991923 |
building | Verbundindex |
bvnumber | BV010937795 |
classification_rvk | XD 3300 XD 3305 |
ctrlnum | (OCoLC)312417634 (DE-599)BVBBV010937795 |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02401nam a2200553 cb4500</leader><controlfield tag="001">BV010937795</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210702 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">960902s1996 gw d||| |||| 10||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">948321539</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805563094</subfield><subfield code="c">kart. : DM 383.00</subfield><subfield code="9">3-8055-6309-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)312417634</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010937795</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3300</subfield><subfield code="0">(DE-625)152554:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3305</subfield><subfield code="0">(DE-625)152554:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New approaches to stabilisation of vaccines potency</subfield><subfield code="b">proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables</subfield><subfield code="c">vol. ed. Fred Brown ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 356 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Developments in biological standardization</subfield><subfield code="v">87</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biologische Standardisierung</subfield><subfield code="0">(DE-588)4336303-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Stabilisierung</subfield><subfield code="0">(DE-588)4357300-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Haltbarkeit</subfield><subfield code="0">(DE-588)4220913-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelstabilität</subfield><subfield code="0">(DE-588)4122835-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1993</subfield><subfield code="z">Genf</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1995</subfield><subfield code="z">Genf</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Stabilisierung</subfield><subfield code="0">(DE-588)4357300-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Biologische Standardisierung</subfield><subfield code="0">(DE-588)4336303-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Haltbarkeit</subfield><subfield code="0">(DE-588)4220913-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Arzneimittelstabilität</subfield><subfield code="0">(DE-588)4122835-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brown, Fred</subfield><subfield code="d">1925-2004</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)171991923</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Developments in biological standardization</subfield><subfield code="v">87</subfield><subfield code="w">(DE-604)BV000000884</subfield><subfield code="9">87</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007316551&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007316551</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1993 Genf gnd-content (DE-588)1071861417 Konferenzschrift 1995 Genf gnd-content |
genre_facet | Konferenzschrift 1993 Genf Konferenzschrift 1995 Genf |
id | DE-604.BV010937795 |
illustrated | Illustrated |
indexdate | 2024-12-23T14:17:37Z |
institution | BVB |
isbn | 3805563094 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007316551 |
oclc_num | 312417634 |
open_access_boolean | |
owner | DE-12 DE-355 DE-BY-UBR DE-11 |
owner_facet | DE-12 DE-355 DE-BY-UBR DE-11 |
physical | XI, 356 S. graph. Darst. |
publishDate | 1996 |
publishDateSearch | 1996 |
publishDateSort | 1996 |
publisher | Karger |
record_format | marc |
series | Developments in biological standardization |
series2 | Developments in biological standardization |
spellingShingle | New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables Developments in biological standardization Biologische Standardisierung (DE-588)4336303-9 gnd Stabilisierung (DE-588)4357300-9 gnd Impfstoff (DE-588)4026655-2 gnd Haltbarkeit (DE-588)4220913-4 gnd Arzneimittelstabilität (DE-588)4122835-2 gnd |
subject_GND | (DE-588)4336303-9 (DE-588)4357300-9 (DE-588)4026655-2 (DE-588)4220913-4 (DE-588)4122835-2 (DE-588)1071861417 |
title | New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables |
title_auth | New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables |
title_exact_search | New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables |
title_full | New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables vol. ed. Fred Brown ... |
title_fullStr | New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables vol. ed. Fred Brown ... |
title_full_unstemmed | New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables vol. ed. Fred Brown ... |
title_short | New approaches to stabilisation of vaccines potency |
title_sort | new approaches to stabilisation of vaccines potency proceedings of a symposium who headquarters geneva may 29 31 1995 80 tables |
title_sub | proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables |
topic | Biologische Standardisierung (DE-588)4336303-9 gnd Stabilisierung (DE-588)4357300-9 gnd Impfstoff (DE-588)4026655-2 gnd Haltbarkeit (DE-588)4220913-4 gnd Arzneimittelstabilität (DE-588)4122835-2 gnd |
topic_facet | Biologische Standardisierung Stabilisierung Impfstoff Haltbarkeit Arzneimittelstabilität Konferenzschrift 1993 Genf Konferenzschrift 1995 Genf |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007316551&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV000000884 |
work_keys_str_mv | AT brownfred newapproachestostabilisationofvaccinespotencyproceedingsofasymposiumwhoheadquartersgenevamay2931199580tables |